SLB vs TERN · P/E 12, rev $35.71B vs $6.12B cap
Schlumberger NV (SLB) versus Terns Pharmaceuticals Inc (TERN) — a side-by-side from cached financials, not a winner call.
Schlumberger NV (SLB) is a oil & gas equipment & services company listed on US.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
Latest reported SLB revenue for 2025-12-31 was $35.71B. Net income was $3.37B. Revenue was down 1.6% from 2024-12-31 to 2025-12-31. SLB currently screens at market cap $48.16B and trailing P/E 12.1.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
SLB currently screens at market cap $48.16B and trailing P/E 12.1. TERN currently screens at market cap $6.12B.
Not investment advice. Open the SLB and TERN stock pages for the full models.
Not investment advice.